Approaches to Inhibiting RAS Driven Tumors Beyond KRAS G12C

Time: 9:00 am
day: Day Two

Details:

  • Targeting the ON form of KRAS G12C
  • Targeting mutant form of RAS beyond G12C
  • Relevant combinations to achieve synergy in KRAS mutant cancers

Speakers: